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The transmembraneglycoproteinE11/Podoplanin (Pdpn) hasbeen implicated in the initial
stages of osteocyte differentiation. However, its precise function and regulatory
mechanisms are still unknown. Due to the known embryonic lethality induced by global
Pdpn deletion, we have herein explored the effect of bone-specific Pdpn knockdown on
osteocyte form and function in the post-natal mouse. Extensive skeletal phenotyping of
male and female 6-week-oldOc-cre;Pdpnflox/flox (cKO)mice and their Pdpnflox/flox controls
(fl/fl) has revealed that Pdpn deletion significantly compromises tibial cortical bone
microarchitecture in both sexes, albeit to different extents (p < 0.05). Consistentwith this,
we observed an increase in stiffness in female cKO mice in comparison to fl/fl mice
(p < 0.01).Moreover, analysis of theosteocytephenotypebyphalloidin staining revealeda
significant decrease in the dendrite volume (p < 0.001) and length (p < 0.001) in cKOmice
in which deletion of Pdpn also modifies the bone anabolic loading response (p < 0.05) in
comparison to age-matched fl/fl mice. Together, these data confirm a regulatory role for
Pdpn in osteocyte dendrite formation and as such, in the control of osteocyte function. As
the osteocyte dendritic network is known to play vital roles in regulating bonemodeling/
remodeling, this highlights an essential role for Pdpn in bone homeostasis.
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1 | INTRODUCTION
Osteocytes are the most numerous of all the cells within bone and are
critical regulators of bone structure and function. Most original
paradigms have proposed that osteocytes are passive in their
formation (Nefussi, Sautier, Nicolas, & Forest, 1991; Palumbo, Ferretti,
& Marotti, 2004; Skerry, Bitensky, Chayen, & Lanyon, 1989). Recent
evidence, however, now indicates that initial “embedding” involves
their active contribution with vital transcriptional and dramatic
morphological transformations (Holmbeck et al., 2005). Osteocytes
have a highly specialized morphology with numerous dendritic
processes extending from their cell body, connecting them with other
osteocytes and with cells lining the bone surfaces, creating a large
syncytium to enable cell–cell communications. Osteocytes play an
integral role in maintaining bone homeostasis by regulating bone
modeling and remodeling through their production of the Wnt
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2017 The Authors. Journal of Cellular Physiology Published by Wiley Periodicals, Inc.
3006 | wileyonlinelibrary.com/journal/jcp J Cell Physiol. 2017;232:3006–3019.
inhibitor sclerostin, and through communicating with bone-resorbing
osteoclasts by RANKL production (Balemans et al., 2001; Dallas,
Prideaux, & Bonewald, 2013; Nakashima & Takayanagi, 2011; Xiong
et al., 2011).
Although it is well recognized that osteocytes are derived from
osteoblasts, the mechanisms which govern this transition (osteocy-
togenesis) are yet to be fully elucidated. Several different genes have
been implicated in influencing osteocytogenesis, one of which
encodes for E11/Podoplanin (Pdpn) (Zhang et al., 2006). Pdpn is
a mucin-like, transmembrane glycoprotein, which undergoes O-
glycosylation leading to the production of different glycoforms. Pdpn
is up-regulated by hypoxia in the lung (Cao, Ramirez, & Williams,
2003), IL-3 and PROX-1 in the lymphatic system (Groger et al., 2004;
Hong et al., 2002), and by TGF-β in fibrosarcoma cells (Suzuki et al.,
2005).
Few studies have investigated the precise function of Pdpn in
osteocytes.We have previously shown that Pdpn is expressed by early
embedding osteocytes, thus identifying it as a factor which likely
contributes to the vital, early stages of osteocyte differentiation
(Staines, Prideaux, et al., 2016). It is known that Pdpn expression in
osteocytes is up-regulated in response to mechanical strain in vivo
(Zhang et al., 2006) and that increased Pdpn expression, through
overexpression in ROS 17/2.6 cells and through stabilization by
proteasome inhibitors in MLO-A5 cells, leads to the formation of long
dendritic processes (Sprague, Wetterwald, Heinzman, & Atkinson,
1996; Staines, Prideaux, et al., 2016). The formation of these
cytoplasmic processes is abrogated in cells pre-treated with siRNA
targeted against Pdpn (Zhang et al., 2006). Although these data support
an important role for Pdpn in dendritic process formation, a key feature
of the differentiating osteocyte, the underpinning mechanisms remain
to be fully defined.
While in vitro studies are informative, to fully disclose the
biological function of Pdpn during in vivo osteocytogenesis and bone
modeling/remodeling, it is essential to study an in vivo model of Pdpn
deletion to enable a thorough examination of its functional role. Global
deletion of Pdpn is perinatally lethal due to the essential role of Pdpn in
lung and epithelial cell function (Zhang et al., 2006).We have therefore
generated a Pdpn conditional knockout mouse to examine how
deletion of Pdpn influences osteocytogenesis and the skeletal
phenotype of these mice. We have used the well characterized
osteocalcin (OC)-cre promotor mouse (Zhang et al., 2002) as the
expression of osteocalcin by late osteoblasts ensures that we eliminate
Pdpn expression from late osteoblasts as they transition to the
osteocyte phenotype. Using an osteocyte-specific cre mouse would
have invalidated our experimental approach as it would have
precluded our ability to study the role of Pdpn in osteocyte formation;
osteoblasts would already have undergone differentiation into
osteocytes. It is also pertinent to add that an osteocyte-specific cre-
promotor mouse does not currently exist. Here, we show that a
significant reduction in the expression of Pdpn in mice affects tibial
microarchitecture, compromises osteocyte dendrite elongation, and
thereby implicating Pdpn as a regulator of both osteocyte form and
function.
2 | RESULTS
2.1 | Oc-cre mediated bone-specific deletion of Pdpn
The genotypes from the breeding strategy were born at the expected
Mendelian frequency, and all cKO mice exhibited survival indistin-
guishable from that of fl/fl control mice. To confirm that the Pdpn
floxed allele was selectively deleted in bone in cKO mice, we
performed PCR analysis using primers designed to specifically detect
Pdpn alleles before (Tm1c) and after (Tm1d) cre-recombination. As
expected, the Tm1d allele was only present in the cKO mice revealing
selective deletion of Pdpn in bone (Figure 1b). The presence of reduced
levels of the retained Tm1c allele in the bones from cKOmice indicates
that complete Pdpn deletion was, however, not achieved (Figure 1b).
This bone-selective hypomorphic expression of Pdpn in cKO mice was
confirmed by immunohistochemical and immunoblotting data. In both
genotypes, immunolabeling for Pdpn showed extensive expression
throughout all soft tissues including the lung, kidney, and liver
(Figure 1c). Pdpn immunolabeling was also observed in the growth
plate chondrocytes of all mice (Figure 1c). Osteoblasts in both the fl/fl
and the cKOmice also stained positively for Pdpn. In the trabecular and
cortical bone of the fl/fl mice, osteocytes and their dendritic processes
exhibited positive immunolabeling for Pdpn (Figure 1d). However, in
the cKOmice, approximately 70%of osteocytes did not label positively
for Pdpn, thereby indicating a significant reduction in bone Pdpn in
these cKO mice (p < 0.001; Figure 1d,e). Similarly, Western blotting
revealed little Pdpn expression in the bones from cKO compared to fl/
fl mice (Figure 1f). Together, these data confirm the hypomorphic loss
of Pdpn expression selectively from bone in our cKO mice.
2.2 | Bone-selective ablation of Pdpn has no effect
on the gross skeletal phenotype
Analysis of total body weight (g) of male or female 6-week-old mice
showed no significant differences between genotypes (male fl/fl:
20.4 ± 0.5; male cKO: 19.1 ± 0.4; female fl/fl: 16.3 ± 0.6; female cKO:
16.2 ± 0.5; n>4/genotype/sex). Similarly, no differences were ob-
served in the tibia lengths (mm) in cKO and fl/fl mice (male fl/fl:
16.2 ± 0.1; male cKO: 16.1 ± 0.2; female fl/fl: 15.6 ± 0.2; female cKO:
15.5 ± 0.1; n > 4/genotype/sex). Whole mount skeletal staining of
mice also revealed no obvious gross differences in Alcian blue or
Alizarin Red staining between cKO and fl/fl mice (Figure 1g,h). Gait
parameters of freely moving mice using the CatWalk gait analysis
system were also unchanged (Supplementary Figure S1). Together
these data suggest that the bone-selective deletion of Pdpn has no
effect on the gross skeletal phenotype of mice.
2.3 | Pdpn deletion significantly alters tibial cortical
bone microarchitecture
Assessment of cortical bone mass by μCT (CSA/mean cortical
thickness) revealed that Pdpn deletion produces statistically signifi-
cant alterations in tibial cortical mass and shape, to differing extents,
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FIGURE 1 (a) Schematic of the Pdpn floxed allele before and after deletion of the loxP cassette containing exon 3 via osteocalcin cre
(Oc-cre) mediated recombination. (b) PCR analysis of genomic DNA from the long bones of fl/fl, and cKO mice with primers for the Tm1c
allele (before cre recombination), and the Tm1d allele (∼440 bp, after cre recombination). (c) Immunohistochemical labeling of Pdpn in the
lung, kidney, spleen, heart, liver, muscle, and growth plate, of 6-week-old mice. Images are representative of n = 4/sex/genotype. Scale
bar = 20 μm. (d) Immunohistochemical labeling of Pdpn in the trabecular bone and cortical bone of 6-week-old mice. Arrows are pointing at
embedded osteocytes within the trabecular and cortical bone and their dendritic processes projecting from the cell bodies. Images are
representative of n = 4/sex/genotype. Scale bar = 20μm. (e) Quantification of osteocytes positive for Pdpn immunolabeling relative to
negatively labeled osteocytes (n = 3/genotype), p < 0.001***. (f) Western blotting for Pdpn (∼37 kDa) in cortical bone protein lysates from
6-week-old mice. β-actin was used as a loading control. Whole mount Alcian Blue and Alizarin Red stained skeletal preparations of 6-week-
old male (g) fl/fl, and (h) cKO mice (scale bar = 10mm) including hindlimb and calvaria preparations (scale bar = 5mm)
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in both male and female cKO compared to fl/fl control mice.
Specifically, CSA is unaffected in female cKO mice but is significantly
lower in male cKO compared with male fl/fl mice at ∼40–65% of
tibial length (p < 0.05; Figure 2a). In addition, mean cross-sectional
thickness was significantly lower at several regions in male cKO
compared to male fl/fl mice (p < 0.05); however, Pdpn deletion
resulted in an increase in mean cross-sectional thickness at several
regions along the tibial length in female cKO compared with fl/fl
control mice (p < 0.05; Figure 2b). Together these data indicate that
the conditional deletion of Pdpn produces a deficit in the cortical
tibial microarchitecture in both male and female mice, with a greater
effect observed in the male mice. Despite this, no significant
differences were observed in the trabecular bone volume/tissue
volume (BV/TV), trabecular number (Tb.N), trabecular thickness (Tb.
th), trabecular separation (Tb.Sp), or trabecular pattern factor (Tb.Pf)
in male or female cKO mice in comparison to age-matched fl/fl
control mice (Table 1).
2.4 | Hypomorphic deletion of Pdpn results in
gender-dependent effects on tibial structural
parameters
To provide an estimate of tibial resistance to bending forces, we
calculated second moment of area around minor (Imin) and major axes
(Imax) (Figure 3a,b). This showed a reduction in Imin along the tibia length
in female cKO compared to female fl/fl which was most pronounced in
midshaft and distal tibia (p < 0.05, Figure 3a). Statically significant
reduction in Imin was also apparent in the tibia of male cKO compared
with their male fl/fl controls, less so at themidshaft butmore proximally
(p < 0.05, Figure 3a). Overall, the trend in cKO mice was for smooth
lowering of Imin proximodistally, which contrasts markedly from
fluctuations in Imin along the tibia length of age-matched fl/fl control
mice. For Imax, the trend was similar for female cKO and their fl/fl
controls (p < 0.05, Figure 3b); however, the effect in male cKO seemed
to be more proximal and midshaft (p < 0.05, Figure 3b). Tibial ellipticity
FIGURE 2 Whole bone analyses of cortical bone between 10% and 90% of total tibial length, excluding proximal and distal metaphyseal
bone, of female fl/fl (brown), female cKO (orange), male fl/fl (black), and male cKO (gray) tibia at 6 weeks of age showing (a) cross-sectional
area (CSA; mm2) and (b) mean cross-sectional thickness (mm). Graphs represent mean ± SEM, n = 4/group. p < 0.05 was considered to be
significant and p ≤ 0.01–0.05 was noted as green, p ≤ 0.001–0.01 as yellow, and p ≤ 0.000–0.001 as red. Not significant is noted as blue
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and resistance to torsion (J) was mostly affected in female cKO
comparedwith female fl/fl (p < 0.05, Figure 3c,d) with only small regions
affected in male cKO compared with their male controls (p < 0.05,
Figure 3c,d). This suggests that tibiae in female cKO are weaker than in
fl/fl control mice. Indeed our 3-point bending data show a 52% increase
in stiffness in the female cKO in comparison to fl/fl mice (p < 0.01;
Table 2). No other significant differences were observed in bone
strength, work to rupture, or maximum load between genotypes in
either gender (Table 2).
2.5 | Bone selective Pdpn hypomorphism does not
affect osteocyte differentiation but causes disruption
of the osteocyte dendritic network
To examine howPdpn deletion affects osteocytogenesis, we examined
the mineralization and differentiation potential of cultured primary
calvaria osteoblasts from Pdpn cKO and fl/fl mice. Alizarin red staining
(Figure 4a) and subsequent quantification (Figure 4b) revealed no
significant differences in the mineralization capabaility of Pdpn cKO
FIGURE 3 Whole bone analyses of cortical bone between 10% and 90% of total tibial length, excluding proximal and distal metaphyseal
bone, of female fl/fl (brown), female cKO (orange), male fl/fl (black), and male cKO (gray) tibia at 6 weeks of age showing (a) Imin (mm
4), (b)
Imax (mm
4), (c) ellipticity, and (d) resistance to torsion (J; mm4) Graphs represent mean ± SEM, n = 4/group. p < 0.05 was considered to be
significant and p ≤ 0.01–0.05 was noted as green, p ≤ 0.001–0.01 as yellow, and p ≤ 0.000–0.001 as red. Not significant is noted as blue
TABLE 1 Trabecular parameters from microCT analysis of 6-week-old male and female fl/fl and cKO mice (n = 4/genotype/sex)
Sex BV/TV (%) Tb.N (μm−1) Tb.Th (μm) Tb.Sp (μm) Tb.Pf (μm−1)
M fl/fl 0.40 ± 0.05 1.14 ± 0.06 28.1 ± 3.53 1.19 ± 0.06 9.84 ± 3.71
cKO 0.38 ± 0.03 1.12 ± 0.07 30.3 ± 1.57 1.11 ± 0.09 10.6 ± 3.12
F fl/fl 0.23 ± 0.03* 1.19 ± 0.02 32.7 ± 1.65 0.96 ± 0.08 5.96 ± 3.05
cKO 0.23 ± 0.03 1.07 ± 0.03 33.2 ± 3.36 1.12 ± 0.08 9.54 ± 2.68
Data are represented as mean ± SEM.
*p < 0.05 in comparison to male equivalent genotype.
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primary osteoblasts in comparison to fl/fl mice. Consistent with this,
we observed no significant differences in the gene expression of the
osteocyte markers Sost and Phex in our Pdpn cKO cells at days 0, 7, 14
and 21 of culture (Figure 4c,d). Similarly, no significant differences in
Dmp1 expressionwere observed at days 0, 7 and 14 although at day 21
of culture, there was a small significant decrease in the expression of
Dmp1 in our Pdpn cKO cultures (p < 0.05; Figure 4e). Taken together,
these data suggest that the bone selective hypomorphic deletion of
Pdpn does not influence osteocyte differentiation.
Due to the proposed role for Pdpn in osteocyte dendrite formation
and elongation, we sought to determine whether Pdpn deletion
modifies osteocyte organization by measuring 3D morphometric
parameters in high-resolution images obtained from nano-CT at the
tibia–fibula junction.Ourmorphometric evaluation of the cortical bone
microarchitecture at the tibia–fibula junction shows that Pdpn deletion
does not affect numbers of osteocyte lacunae (N.Lc/Ct.TV; Table 3) or
lacunar volume (Lc.V/Ct.TV; Table 3). Interestingly, no significant
effect on vascular porosity; canal number (N.Ca; Table 3), density
(N.Ca/Ct.TV; Table 3) and volume (normalized by cortical tissue
volume; Ca.V/Ct.TV; Table 3) was also evident in cKO bones.
Due to the reported function of the osteocyte in regulating bone
remodeling and phosphate homeostasis, we next sought to examine
whether our cKO mice exhibit differential expression of the osteocyte
factor sclerostin, as well as serum phosphate. We observed no
apparent differences in the expression of sclerostin in our cKOmice in
comparison to fl/fl mice (Figure 4f). Similarly, our assessment of
osteoclast and osteoblast numbers by TRAP and H&E staining,
respectively and found no significant differences in their number
between cKO and fl/fl mice (Figure 4g,h). Serumphosphate levelswere
also similar in cKO and fl/fl mice (Figure 4i). The osteocyte and its
canalicular-lacunar organization also have another pivotal role in the
bone’s adaptive response to mechanical stimuli. We therefore next
sought to examine whether tibiae deficient in Pdpn exhibit a modified
response to mechanical loading. As expected, and in line with previous
data, fl/fl mice show a significant load-induced increase in cortical
bone cross-sectional thickness at the proximal diaphysis region of the
tibia (p < 0.01, Figure 5a–c). Although the scale of the load-induced
increase was statistically smaller than in fl/fl mice (p < 0.05), cKO mice
also exhibited a significant increase in the tibial cross-sectional
thickness in response to loading (p < 0.05, Figure 5a–c; compared to
contralateral control). As expected, in both our fl/fl and cKO mice, a
decrease in sclerostin immunolabeling was observed in cortical bone
osteocytes of the loaded limb in comparison to osteocytes of the
unloaded contralateral limb (Figure 5d). There were, however, no
differences in osteocyte sclersotin expression between loaded bones
from fl/fl and cKO mice (Figure 5d).
In the light of the relatively normal osteocyte organization in cKO
mice as disclosed by nano-CT (Table 3), the difference in response of
cKO and fl/fl control mice to mechanical loading was somewhat
surprising. Therefore, to determine whether this deficit in load-related
bone adaptation was associated with any specific change in osteocyte
morphology, we next performed phalloidin staining of F-actin in fl/fl
and cKO cortical bone. Subsequent 3D rendering (Figure 5e) and
quantitative analysis of osteocytes in the diaphyseal cortical bone
confirmed our nano-CT data and revealed no significant differences in
the total number of osteocyte cell bodies (Figure 5f), the osteocytes
cell body volume (Figure 5g), or the osteocyte cell body sphericity
(Figure 5h) in cKO bone in comparison to age-matched fl/fl bone.
Similarly, no significant differences were observed in the number of
dendrites formed (Figure 5i). However, a significant decrease in the
mean dendrite volume (Figure 5j, p < 0.001) and the dendrite lengths
(Figure 5k, p < 0.001) was noted in cKO in comparison to fl/fl mice,
suggestive of a role for Pdpn in attainment of fully developed
dendrites.
3 | DISCUSSION
We, and others, have previously shown that Pdpn promotes
osteocytogenesis and dendrite formation in vitro (Staines, Prideaux,
et al., 2016; Zhang et al., 2006). Our studies, described herein, have for
the first time successfully generated a bone-specific conditional Pdpn
hypomorphic mouse and we have confirmed a role for Pdpn in the
attainment of fully elongated osteocyte dendrites.
Previous attempts to decipher the in vivo role of Pdpn in
osteocytogenesis have involved global deletion of Pdpn in mice. In the
lung, Pdpn is known as T1alpha or RT140 and it is expressed on the
apical surface of the lung epithelial cells (Dobbs, Williams, & Gonzalez,
1988; Rishi et al., 1995). In mice, global deletion of this gene results in
death at birth due to respiratory failure. This is associated with the
TABLE 2 3-point bending analysis of 6-week-old male and female fl/fl and cKO mice (n = 4/genotype/sex)
Sex
Maximum
load (N)
Deflection at
maximum
load (mm)
Work to
maximum load
(J)
Stiffness
(N/m)
Load at
rupture (N)
Deflection at
rupture (mm)
Work to
rupture (J)
M fl/fl 5.81 ± 0.65 0.60 ± 0.09 0.002 ± 0.00 17.7 ± 0.66 4.06 ± 0.45 0.80 ± 0.14 0.003 ± 0.00
cKO 5.95 ± 0.26 0.78 ± 0.14 0.002 ± 0.00 16.4 ± 0.97 4.22 ± 0.19 1.08 ± 0.16 0.004 ± 0.00
F fl/fl 4.58 ± 0.34 0.66 ± 0.04 0.002 ± 0.00 12.6 ± 1.42 3.21 ± 0.24* 0.90 ± 0.02 0.002 ± 0.00
cKO 5.30 ± 0.51 0.68 ± 0.06 0.002 ± 0.00 19.1 ± 1.44** 3.88 ± 0.36 0.96 ± 0.11 0.003 ± 0.00
Data are represented as mean ± SEM.
*p < 0.05 in comparison to male equivalent genotype.
**p < 0.01 in comparison to female fl/fl. Data are represented as mean ± S.E.M.
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failure of type II alveolar lung cells to differentiate into type I cells and
as such, the lungs of thesemice are unable to inflate as normal (Ramirez
et al., 2003). T1alpha deletion in mice also produces lymphatic defects
with pronounced lymphedema resulting in swelling of the limbs at birth
(Schacht et al., 2003). A previous comprehensive study has attempted
to analyze the effect of Pdpn deletion on the skeleton by generating a
global Pdpn knock-out mouse by targeting exon 1 (Zhang et al., 2006).
While these mice did not express Pdpn in bone, the animals died soon
FIGURE 4 (a) Alizarin red staining of primary osteoblast cultures from Pdpn cKO and fl/fl mice over a 21-day culture period. (b)
Quantification of Alizarin red staining. RT-qPCR analysis of osteocyte marker genes (c) Sost, (d) Phex, and (e) Dmp1 in mineralizing primary
osteoblast cultures from Pdpn cKO and fl/fl mice over a 21-day culture period. (f) Immunohistochemical labeling of sclerostin in the cortical
bone of 6-week-old mice. Arrows are pointing at embedded osteocytes within the cortical bone and their dendritic processes projecting from
the cell bodies. Images are representative of n = 4/sex/genotype. Scale bar = 20 μm. (g) Osteoclast cell numbers (OC.N/mm2) in the trabecular
bone of 6-week-old cKO and fl/fl mice (n = 4/genotype). (h) Osteoblast cell numbers (OB.N/mm bone surface [BS]) in the trabecular bone of
6-week-old cKO and fl/fl mice (n = 4/genotype). (i) Serum phosphate levels in cKO and fl/fl mice (n = 6/genotype). Data are represented as
mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001
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after birth from suspected lung defect. Although the authors were
unable to study the effects of Pdpn deletion on the postnatal skeleton,
they were able to make some important observations. The general
appearance of the embryonic Pdpn null andwild-typemice was similar.
More specifically, they found no significant differences in the length or
diameter of the femur, or in the femur cortical thickness. They did
report an increase in the body weight of the Pdpn null mice, however
this was attributed to lymphedema resulting from limb swelling (Zhang
et al., 2006).
By using the cre-LoxP system targeted to exon 3 of the Pdpn gene,
we have generated bone-specific conditional knockdown mice which
exhibited survival indistinguishable from that of fl/fl control mice. This
has for the first time allowed us to study the role of Pdpn in bone
development in the post-natal mouse. The normal survival rates of
cKO mice contrasts with perinatal lethality of global Pdpn-/- mice
(Zhang et al., 2006). Here, we used the well characterized osteocalcin-
driven cre promotor to drive Pdpn deletion. Oc-cre expression has
previously been reported to be exclusive to late osteoblasts, with onset
of expression just before birth and continuing throughout the mature
osteoblast lineage (Zhang et al., 2002). This has therefore allowed us to
examine the structure and function of the postnatal skeleton in the
presence of reduced Pdpn expression in bone, where we observed
significant differences in tibial cortical bone microarchitecture and in
the volume and length of osteocyte dendrites likely leading to
downstream effects on the tibia’s anabolic response to loading.
Osteocytes play a vital role in regulating bone remodeling and
their vast dendritic network is critical to cell–cell communication,
maintaining cell viability and allowing the transfer of nutrients and
waste products (Dallas et al., 2013). Accumulating evidence has
suggested that Pdpn may play a critical role in dendrite formation; in
MLO-Y4 cells, the deletion of Pdpn with siRNAs abrogated dendrite
formation (Zhang et al., 2006). Conversely, the ectopic overexpression
of Pdpn in keratinocytes induces plasma membrane extensions (Scholl,
Gamallo, Vilaro, & Quintanilla, 1999), and in endothelial cells, the
reorganization of the actin cytoskeleton and the formation of long tube
like structures (Schacht et al., 2003). Similarly, we have previously
shown that stabilization of Pdpn protein, through inhibition of
endogenous proteasome activity, promotes dendrite formation
through the RhoA/ROCK/ERM pathway (Staines, Prideaux, et al.,
2016). RhoA is a small GTPase and a master regulator of various
cellular processes such as cytokinetics, cytoskeletal regulation, and cell
migration (Takai, Sasaki, & Matozaki, 2001). Pdpn is able to co-localise
with the ezrin, radixin and moesin (ERM) family of proteins which are
essential for the linkage of the actin cytoskeleton to the plasma
membrane (Martín-Villar et al., 2006, 2014; Scholl et al., 1999). Our
present data suggests that Pdpn deletion does not affect osteocyte
differentiation and instead, strongly support a role for Pdpn in the
formation of full length dendritic processes. Despite this, we did not
observe any differences in the expression of factors involved in the
osteocytic regulation of bone remodeling and phosphate homeostasis.
Normal sclerostin expression in osteocytes within bone of Pdpn cKO
mice is consistent with a lack of change in osteocyte number, shape
and size in these mice. It is possible that the hypomorphic deletion of
Pdpn expression in osteocytes does not affect the osteocyte’s ability to
regulate bone remodeling. Rather, the decreased magnitude of bone
accrual in response to mechanical loading is likely a consequence of
inadequate dendrite formation and a lack of critical osteocyte
mechanoregulatory function.
Mechanosensation and mechanotransduction were the earliest
functions ascribed to the osteocyte and since then, there has been a
wealth of evidence defining their role and in particular, the role of the
dendritic network in sensing mechanical loads. In recent years, the
complex biochemical pathways through which the osteocyte converts
its mechanical strain signals into a biological output have been
unravelled. These include intracellular calcium, nitric oxide, ATP, and
prostaglandins and these have direct effects on osteoblasts to alter the
bonemicroarchitecture (Dallas et al., 2013). On this basis, we therefore
speculate that the restricted osteocytic dendrite network observed in
our hypomorphic Pdpn cKO mice would likely lead to altered bone
geometry and microarchitecture; the reduced dendritic network
impairs the ability of the osteocyte to sense load and convert this to
a biological signal affecting osteoblast function. It would obviously
therefore be of interest to examine the expression of the aforemen-
tioned biochemical pathways in our Pdpn cKO mice in response to
TABLE 3 Porosity parameters representing lacuna and vascular porosity of fl/fl and cKO mice detailing the effect of genotype
Morphometric index fl/fl n = 4 cKO n = 4 Effect of genotype
Bone parameter
Ct.TV (mm−3) 0.101 ± 0.017 0.078 ± 0.003 NS
Canal parameters
N.Ca 52 ± 14.634 34 ± 12.124 NS
N.Ca/Ct.TV (mm−3) 530 ± 169.45 419 ± 134.24 NS
Ca.V/Ct.TV (%) 0.005 ± 0.001 0.003 ± 0.001 NS
Lacunae parameters
N.Lc 1792 ± 353 1037 ± 383 NS
N.Lc/Ct.TV (mm−3) 18611 ± 4505 13083 ± 4497 NS
Lc.V/Ct.TV (%) 0.004 ± 0.000 0.003 ± 0.000 NS
Data represent means ± SEM with group sizes of n = 4 for fl/fl and cKO mice.
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FIGURE 5 Representative images of fl/fl and cKO mice in (a) control and (b) loaded limbs. (c) Cortical cross-sectional thickness at 37% of
the tibia length as assessed by microCT analysis. (d) Immunohistochemical labeling of sclerostin in osteocytes of cortical bone of loaded and
control 6-week-old Pdpn cKO and fl/fl mice. Arrows are pointing at embedded osteocytes within the cortical bone and their dendritic
processes projecting from the cell bodies. Images are representative of n = 4/sex/genotype. Scale bar = 20μm. (e) Laser confocal z-stack, single
channel outlining phalloidin-Factin staining was imaged in the cortical bone. Imaris cell surface rendering was applied to cell bodies and Imaris
FilamentTracer applied to dendritic processes and these were colored according to length. Quantification of osteocyte parameters in 6-week-
old male fl/fl, and cKO. (f) Total number of complete cell bodies in three volume fields. (g) Cell body volume (μm3). (h) Cell body sphericity.
(i) Total number of dendrites in three volume fields. (j) Dendrite volume (μm3). (k) Dendrite length (μm). Data are represented as mean ± SEM.
*p < 0.05, **p < 0.01, ***p < 0.001
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loading. Moreover, as the bone mechanical properties, including
stiffness, depend upon the geometry of the bone shaft, it is likely that
the reduction of the osteocyte dendritic network affects the
mechanical properties as a secondary effect through these changes
in the microarchitecture (Saffar, Jamilpour, & Rajaai, 2009).
Here, we used whole bone μCT analysis to fully define these
changes in microarchitecture and determine the estimated strength
and rigidity of the bone through the study of the bone’s cross sectional
geometry. CSA is directly related to a bone’s strength against
compressive forces applied equally throughout the bone; factors
such as bone shape and the effects of muscle contraction, however,
result in long bones experiencing bending and torsional forces
(Javaheri et al., 2015). We measured indices of rigidity, including
maximum and minimum resistance against bending forces in the cross
section, second moment of area around minor axis (Imin), and second
moment of area around major axis (Imax) in male and female cKO tibia
and their age-matched control mouse tibia. Our data, using this
approach, revealed sex-dependent differences in cortical bone
microarchitecture and in our estimation of tibial resistance to bending
forces in cKO mice in comparison to control mice. These differences
suggest that bone responses to dysfunctional osteocyte form and
function may be sex-dependent. Similarly, the differences in the
regional responses in both male and female bones suggest that Pdpn
may play differential roles in bone development and function.
Interestingly, Bonewald and colleagues found osteocyte Pdpn
expression was increased in an ulna loading model, but that this
increase was not consistent along the length of the diaphysis (Zhang
et al., 2006). This regional requirement for Pdpn function during
physiological loading in the post-natal mouse may explain the
differences noted in structural parameters of the Pdpn cKO mouse
and in the relatively minor, albeit significant, reductions in load-related
increases in cortical thickness in the bones of these mice.
Despite these changes in bone microarchitecture and osteocyte
form inourPdpn cKOmice, ourdata reveal noeffectofPdpndeletionon
the gross phenotype. This suggests that while Pdpn plays a role in
dendrite length and bone microarchitecture, there may be redundancy
associated with the function of Pdpn. Possible candidates include
Dentin matrix protein 1 (DMP1). DMP1 is an acidic phosphorylated
extracellular matrix protein that is part of the Small; Integrin-Binding
LIgand, N-linked Glycoprotein (SIBLING) family along with bone
sialoprotein (BSP), osteopontin (OPN), dentin sialophosphoprotein
(DSPP), and matrix extracellular phosphoglycoprotein (MEPE). All of
these family members contain an RGD sequence for integrin binding
and canbind to hydroxyapatite (Staines,Macrae,&Farquharson, 2012).
DMP1 is highly expressed by osteocytes and is restricted to the
dendritic processes. Deletion of DMP1 in mice causes remarkable
defects in both tooth and bone (Ye et al., 2004, 2005). DMP1 knockout
mice also display an abnormal lacuna-canalicular system, with a
reduction in thenumberof canaliculi anda twofold expandedosteocyte
lacunae with rough, not smooth, lacunar walls (Lu et al., 2011). The
authors of this elegant study also showed that this phenotype can be
rescued by the re-expression of the 57-kDa C-terminal fragment of
DMP1 (Lu et al., 2011). DMP1 has been demonstrated to bind to the
hyaluronan receptor CD44, a membrane bound protein thought to
interact with the ERM family of proteins that are involved in actin
cytoskeleton rearrangement and as such, the formation of the
osteocyte dendritic processes (Jain, Karadag, Fohr, Fisher, & Fedarko,
2002).
As we did not achieve complete cre-recombination and conse-
quently not a complete knock-out of Pdpn expression (∼70%
reduction), it is also possible that a low level of Pdpn expression is
sufficient to drive osteocytogenesis. A more complete knock-out of
Pdpn expression may be required to reduce dendrite formation to a
level where bone function is pathologically compromised. Our decision
to use the osteocalcin-cre promotor mouse to drive deletion of Pdpn
selectively in bonewas based on the onset ofOCNexpression. Despite
this, there have been previous reports of incomplete recombination
when using these mice (Xiao et al., 2010). As such it might be prudent
to attempt another cre driver mouse. Such examples would include the
col 2.3 kb (Col 2.3-Cre) and 3.6 kb (Col 3.6-Cre) fragments of the rat
Col1a1 promoter or the osterix-cre mouse (Liu et al., 2004; Rodda &
McMahon, 2006).
In summary, our data confirm a role for Pdpn in the formation of
full length dendritic processes during osteocytogenesis and suggest
that dysfunctional osteocyte dendrite formation is sufficient to alter
the bone microarchitecture. The generation of a viable post-natal
bone specific Pdpn cKO will enable future research into understand-
ing the importance of Pdpn in osteocyte function, and in particular to
the in vivo effects of dysfunctional osteocyte formation on bone
homeostasis.
4 | MATERIALS AND METHODS
4.1 | Generation of a Pdpn conditional knockout
mouse
We obtained floxed Pdpn mice from the EUCOMM/KOMP, MRC
Harwell, Oxfordshire, UK and OC-cre mice as a kind gift from Thomas
Clemens at John Hopkins Medicine, Baltimore, Maryland (Zhang et al.,
2002). Pdpn floxedmice were designedwith the loxP sites around exon
3 (Figure 1a). Mice were crossed to generate Oc-Cre;Pdpnflox/flox
conditional knockout mice (cKO) as well as appropriate Pdpnflox/flox
control mice (fl/fl). PCR-based genotyping was performed on mouse
DNA using a duplex PCR reaction for Cre (F: GCA TTA CCG GTC GAT
GCA ACG AGT GAT GAG; R: GAG TGA ACG AAC CTGGTC GAA ATC
AGT GCG) and Fabpi200 (F: TGG ACA GGA CTG GAC CTC TGC TTT
CCT AGA; R: TAG AGC TTT GCC ACA TCA CAG GTC ATT CAG) and
for Pdpn (F: TCC CAC ACC AGG TTT TGT GT; R: CAG TGA GCC ATC
TCT CCA GC). Mice were kept in polypropylene cages, with light/dark
12-hr cycles, at 21 ± 2°C, and fed ad libitum with maintenance diet
(Special Diet Services, Witham, UK). All experimental protocols were
approved by Roslin Institute’s Animal Users Committee and the
animals were maintained in accordance with UK Home Office
guidelines for the care and use of laboratory animals. All analysis
and data acquisition were completed on 6-week-old mice and tissue
obtained from them.
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4.2 | Determination of Cre-mediated recombination
efficiency
To determine the specificity and efficiency of Cre-mediated recombina-
tion, PCR analysis was performed on genomic DNA extracted from
bones using a Qiagen, Manchester, UK DNA extraction kit according to
the manufacturer’s instructions. Primers were specific for alleles before
recombination (Tm1c; F: TGGAATGGCTGTGAGTTCTG; R: CTAAAA
TGGAGTTGGAGATGGATAC)andafter recombination (Tm1d; F:TGA
GCG AGC AGA GGT CCT AA; R: GCG TCT GGC ACT CTC AGA AG).
4.3 | Primary osteoblast isolation and culture
Primary calvarial osteoblasts were obtained from 3-day-old Pdpn cKO
and fl/flmice by sequential enzymedigestion of excised calvarial bones
using a four-step process as has previously been described (Staines,
Zhu, Farquharson, & Macrae, 2013) (1 mg/ml collagenase type II in
Hanks’ balanced salt solution [HBSS] for 10min; 1 mg/ml collagenase
type II in HBSS for 30min; 4 mM EDTA for 10min; 1 mg/ml
collagenase type II in HBSS for 30min). The first digest was discarded
and the cells were resuspended in growth medium consisting of a-
MEM (Invitrogen, Paisley, UK) supplemented with 10% (v/v) FCS
(Invitrogen) and 1% gentamycin (Invitrogen). Osteoblasts were seeded
at a density of 1 × 104 cells/cm2 and cultured for up to 21 dayswith the
addition of 2.5mM β-glycerophosphate and 50 µg/ml ascorbic acid. At
days 0, 7, 14, and 21, cells were either processed for RNA extraction or
fixed in 4% paraformaldehyde and stainedwith 2% alizarin red (pH 4.2)
for 5min at room temperature. Alizarin red-stained cultures were
extracted with 10% cetylpyridinium chloride for 10min and optical
density was measured at 570 nm.
4.4 | Gait analysis
Gait parameters of freely moving male mice were measured using the
CatWalk gait analysis system (Noldus Information Technology, the
Netherlands) as described previously (Hamers, Lankhorst, van Laar,
Veldhuis, &Gispen, 2001;Masocha&Parvathy, 2009). Eachmousewas
placed individually in the CatWalk walkway and allowed to walk freely
and traverse fromone side to the other of thewalkway glass plate.Mice
were habituated every day for 2weeks prior to the test run, inwhich the
gait of allmicewas recorded three timesandanalyzedusing theCatWalk
system.Analysis of the recording generated awide range of parameters;
those analyzed are detailed in Supplementary Table S1.
4.5 | In vivo loading
Twelve-week-old male mice were isoflurane-anesthetized and the
right tibia loaded as described previously using a well-established
model for comparing architectural load-induced changes in tibiae in
control and mutant mice in which the contralateral left tibia is used as
control (De Souza et al., 2005). Briefly, axial compressive loads were
applied by a servo-hydraulic materials testing machine (Bose,
Framingham, Massachusetts, UK) via custom-made cups which hold
knee and ankle joints flexed and the tibia vertically. The loading pattern
consisted of a trapezoidal wave, with peak 11N loads for the cKO and
12N for the WT mice for 0.05 s, rise and fall times 0.025 s each and
baseline hold time of 9.9 s at 2 N (calibrated for peak strain level by
finite element analysis) (Pereira, Javaheri, Pitsillides, & Shefelbine,
2015). Forty cycles were applied in each loading episode. Twelve-
week-old male cKO and WT mice (n > 3/genotype) were loaded three
times per week for 2 weeks and left and right tibia dissected 3 days
after the final loading episode.
4.6 | Whole mount staining
Male mice were euthanized by CO2 and incubated for 24 hr in tap
water. Carcasses were then scalded in hot tap water to enable removal
of the skin, skinned, and eviscerated, and then fixed in 95% ethanol for
3–5 days. The preparations were then incubated in 0.015%Alcian blue
(pH 0.75) for 24 hr to stain sulphated glycosaminoglycans in the
cartilage, rinsed twice in 95% ethanol, and fixed in 95% ethanol for
another 2 days.Micewere then cleared of the remainingmuscle by a 6-
hr incubation in 1% KOH (w/v) and the bone was stained with fresh
0.005% Alizarin Red for 3 hr. Mice were then further cleared in 2%
KOH (w/v) for 48 hr followed by decreasing concentrations of 2%
KOH (w/v) in glycerol for 24 hr each (80:20, 60:40, 40:60, and 20:80,
respectively). The skeletal preparations were stored in 20:80 2% KOH:
glycerol at room temperature.
4.7 | Tissue processing for histological techniques
Soft tissues (liver, spleen, lung, heart, and kidney) and tibia/femurs
were dissected from freshly killed male and female mice and fixed in
4%paraformaldehyde (PFA) for 24 hr at 4°C. Tibiaewere subsequently
decalcified in 10% ethylenediaminetetracetic acid (EDTA/PBS, pH 7.4
at 4°C; Sigma–Aldrich, Dorset, UK) for 3–4 weeks with regular
changes. Soft tissues and legs were dehydrated and processed to
paraffin wax using standard procedures. Sections (5 μm) were cut and
used for histological and immunohistochemical analysis. To analyze
osteoclast and osteoblast numbers, sections were reacted for tartrate-
resistant acid phosphatase activity (TRAP) and stained by H&E
respectively, as described previously (Erlebacher & Derynck, 1996).
Osteoclasts were quantified per mm2 of trabecular bone, and
osteoblasts per mm of bone surface, in an identical region at an
equivalent distance beneath the growth plate in all samples.
4.8 | Immunohistochemistry
For immunohistochemical analysis, sections were dewaxed in xylene
and rehydrated. Sections were incubated at 37°C for 30min in 1mg/
ml trypsin for antigen demasking. Endogenous peroxidases were
blocked by treatment with 3% H2O2 in methanol (Sigma). Ppdn
antibodies (Polyclonal raised in Goat IgG; R&D systems, Abingdon, UK)
were used at a dilution of 1/100; and sclerostin antibodies (Polyclonal
raised in Goat IgG; R&D systems) at a dilution of 1:200 with
appropriate IgG controls. The Vectastain ABC universal kit (Vector
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Laboratories, Peterborough, UK) was used according to the manu-
facturer’s instructions. The sections were dehydrated, counterstained
with hematoxylin, and mounted in DePeX.
4.9 | Phalloidin staining
Femurs from male mice were decalcified as described above and
then cryoprotected in 30% sucrose (w/v) at 4°C for 48 hr. The
femora were cut in the mediolateral plane in serial longitudinal
20-μm thick sections using a cryostat and thaw-mounted on gelatin-
coated slides for processing. Slides were dried at room temperature
for 45 min, washed in PBS twice for 5 min each, and incubated with
0.1% Triton-X 100 (Sigma–Aldrich) for 30 min and then rinsed with
PBS. Slides were then incubated with Alexa Fluor 488-conjugated
phalloidin (1:20; Life Technologies, Grand Island, NY) for 1 hr. Bone
sections were washed in PBS and mounted in VectaShield (Vector
Laboratories). Preparations were allowed to dry at room temperature
for 12 hr.
4.10 | Analysis of phalloidin staining
Sections were imaged on a Zeiss LSM 710 Laser Scanning Confocal
Microscope with 488 nm laser excitation and detection settings from
493 nm to 634 nm. Z-stacks were produced with optimal Nyquist
overlap settings using a 63×/1.4na oil immersion lens. Voxel sizeswere
0.1 × 0.1 × 1.00 μm in x,y,z planes. respectively. A comparable region of
interest was analyzed for osteocyte parameters in all samples located
in the diaphyseal cortical bone. Image stacks were imported into
Bitplane Imaris 8.2.0 software and algorithmswere createdwith Imaris
FilamentTracer to render and measure dendritic processes. Surface
rendering was used for osteocyte cell body measurements.
4.11 | Micro-computed tomography (μCT) scanning
Tibiae from male and female mice were dissected and frozen at
−20°C until required. Scans were performed with an 1172 X-Ray
Microtomograph (Skyscan, Belgium) to evaluate bone geometry. High-
resolution scans with an isotropic voxel size of 5 μm were acquired
(50 kV, 200 μA, 0.5 mm aluminum filter, 0.6° rotation angle, two frame
averaging, exposure time 1650). The projection images were
reconstructed using NRecon software version 1.6.9.4 (Skyscan,
Belgium) to produce tomograms that underwent processing during
reconstruction to correct for beam-hardening and ring artifacts.
4.12 | Morphometrical analysis
4.12.1 | Trabecular bone
For the trabecular analysis, the base of the growth plate was used as a
standard reference point. Trabecular bone was analyzed in a 1-mm
region of the proximal tibia 250 μm from this reference point (toward
the diaphysis). Data were analyzed with CtAn software (Skyscan) as
previously described (Staines, Madi, et al., 2016).
4.12.2 | Whole bone cortical μCT analysis
Whole bone analysis was performed on datasets derived from whole
CT scans using BoneJ (version 1.13.14) a plugin for ImageJ, as
previously described (Javaheri et al., 2015). Following segmentation,
alignment, and removal of fibula from the dataset, a minimum bone
threshold was selected using a histogram-based method in ImageJ
which utilizes all pixels in a stack to construct a histogram and was
further confirmed using ImageJ “threshold function.” The gray level
threshold ranged between 22,000 and 22,100 and was applied to all
datasets to separate higher density bone from soft tissues and air. This
threshold was used in “Slice Geometry” function within BoneJ to
calculate bone cross sectional area (CSA), second moment of area
around the minor axis (Imin), second moment of area around the major
axis (Imax), mean cortical thickness determined by local thickness in two
dimensions (Ct.Th), ellipticity and resistance to torsion (J). The most
proximal and distal (10%) portions of the tibial length were excluded
from analysis, as these regions include trabecular bone.
4.13 | Nano-computed tomography analysis
The samples were placed in Orthodontic Wax (Kerr, CA) at 50 kV and
200µA,9,800-msexposure timewith a0.25-mmaluminumfilter (99.999%
purity,Goodfellow,Huntington,UK), voxel sizeof0.6µm,360°at a rotation
stepof0.25°.Two-frameaveragingwasused to improve thesignal-to-noise
ratio. We analyzed 300 consecutive images from the tibia–fibula junction
fromeach sample.Using theCtAn software, osteocyte lacunar indiceswere
calculated by measuring the 3D parameters of each discreet object within
the volume of interest after segmentation as described previously (Javaheri
et al., 2015). Shape analysis of the lacunaewas conducted utilizing “Analyze
Particles” function in BoneJ.
4.14 | Mechanical testing
A Lloyd LRX5 materials testing machine (Lloyd Instruments, West
Sussex, UK) fitted with a 100N load cell was used to determine bone
stiffness and point of failure of tibiae. The spanwas fixed at 10 mm, and
the cross-head was lowered at 1 mm/min. Data were recorded after
every 0.2-mm change in deflection. Each bone was tested to failure,
with failure points being identified as the point of maximum load from
the load–extension curve. The maximum stiffness was defined as the
maximumgradient of the rising portionof this curve (Huesa et al., 2011).
4.15 | RNA extraction and quantitative real-time PCR
(RT-qPCR)
Total RNAwas extracted using the RNEasy mini kit (Qiagen) according
to the manufacturer’s instructions. RNA samples were reverse-
transcribed into cDNA using Superscipt II reverse transcriptase
(Invitrogen). RT-qPCR was carried out in a Stratagene Mx3000P
cycler with each reaction containing 50-ng template DNA, 250 nM
forward and reverse primers (PrimerDesign, SouthamptonUK) (Sost: F:
TGAGAACAACCAGACCATGAAC, R: TCAGGAAGCGGGTGTAGTG;
Dmp1: F: ATACCACAATACTGAATCTGAAAGC, R: CACTATTTGCCTG
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TCCCTCTG; Phex: F: CTAACCACCCACTCCCACTT, R: CCAATA-
GACTCCAAACCTGAAGA; Atp5b: sequences not available) and Pre-
cisionPlus Mastermix (Primer Design). The Ct values for the samples
were normalized to that of GAPDH and the relative expression was
calculated using the ΔΔCt method (Livak & Schmittgen, 2001). The
amplificationefficienciesof all theprimerswerebetween90%and100%.
4.16 | Western blotting
Femurs frommalemice had their epiphyses removed andwere flushed to
remove bone marrow, snap frozen, and lysed in RIPA buffer (Sigma),
containing protease inhibitors (Roche, Burgess Hill, UK). Protein content
was determined using the DC protein assay (Bio-Rad Laboratories,
Watford, UK). The lysates were run on 10% Bis–Tris gels. Following
transfer, nitrocellulose films were blocked in 5% milk, and probed
overnightat4°CwithPdpnprimaryantibody (R&DSystems;1:1,000). The
nitrocellulosewas subsequently incubatedwith peroxidase-labeled rabbit
anti-goat antibodies (Dako, Ely, UK) for a further 90 min. ECL detection
reagentswereused tovisualizebandsonhyperfilm (GEHealthcare,Bucks,
UK).Where necessary, the nitrocellulose was stripped using Restore Plus
Stripping Buffer (GE Healthcare). Densitometry of Western blotting was
measured on three independent samples using ImageJ.
4.17 | Serum phosphate analysis
Immediately before termination, bloodwas collected and incubated on
ice for 30min, before centrifugation at 15,000 kg for 10min. The
serum supernatant was stored at −80°C until analyzed for phosphate
levels using a colorimetric Phosphate Assay Kit (Abcam, Cambridge,
UK; 1:100) according to the manufacturer’s instructions.
4.18 | Statistical analysis
Data are expressed as the mean ± SEM of at least three replicates per
experiment. Results were analyzed blinded. For cortical bone, graphs
were developed using the R programming language “R,” version 3.1.3
(R Foundation for Statistical Computing, Vienna, Austria; http://www.
r-project.org). Normality and homogeneity of variance of all the data
were checked using the Shapiro–Wilk and the Bartlett’s test in R 3.1.3,
respectively. Two-sample Student’s t-test was used to comparemeans
between female cKO and fl/fl, and between male cKO and fl/fl.
Kruskal–Wallis test was employed if either the normality or the
homogeneity of variance assumptions were violated (p ≥ 0.05).
p < 0.05 was considered to be significant and noted as *; p-values of
<0.01 and <0.001 were noted as ** and ***, respectively.
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